Skip to main content
Rural Health Information Hub
Rural Health Information Hub

Rural Health
News by Topic: Pharmacy and prescription drugs

Jun 14, 2024 - Pre-publication notice of final rule from the Centers for Medicare & Medicaid Services (CMS) revising the Medicare Prescription Drug Benefit (Part D) and Office of the National Coordinator for Health Information Technology (ONC) regulations to implement changes related to required standards for electronic prescribing and adoption of health information technology (IT) standards for Department of Health and Human Services (HHS) use. Among other things, CMS will require Part D sponsors, prescribers, and dispensers of covered Part D drugs for eligible individuals to comply with standards CMS has either adopted directly or is requiring by cross-referencing ONC standards for electronically transmitting prescriptions and prescription-related information. These regulations are effective 30 days after the publication of this notice, which is scheduled for June 17, 2024.
Source: Federal Register
May 23, 2024 - The Substance Abuse and Mental Health Services Administration (SAMHSA) will hold a virtual public meeting of the Interdepartmental Substance Use Disorders Coordinating Committee (ISUDCC) on June 10, 2024, from 1:00 – 5:00 p.m. Eastern. The ISUDCC agenda will focus on the ISUDCC's recommendations to HHS on how the Federal Government can further integrate and coordinate harm reduction approaches and strategies across the continuum of prevention, treatment, and recovery policies, programs, and practices. Agenda items will also include presentations on the recently released harm reduction framework, the Naloxone Saturation Academies, and SAMHSA's Overdose Prevention and Response Toolkit. Information on how to join the meeting will be posted on the SAMHSA website.
Source: Federal Register
May 17, 2024 - The Food and Drug Administration has revoked Emergency Use Authorizations issued to Bio-Rad Laboratories Inc., and Fast Track Diagnostics Luxembourg S.á.r.l. (A Siemens Healthineers Company) related to COVID-19 detection and diagnosis tests.
Source: Federal Register
May 16, 2024 - The Food and Drug Administration has issued an Emergency Use Authorization for certain medical devices related to the COVID-19 pandemic. These authorizations are effective on their date of issuance.
Source: Federal Register
May 14, 2024 - Profiles an independent pharmacy in Lillington, North Carolina, where pharmacists guide women through the process of understanding what contraceptives are available. North Carolina health leaders are promoting the ongoing expansion of reproductive medicine across the state.
Source: Spectrum News 1
May 7, 2024 - Highlights the University of Tennessee Health Science Center College of Pharmacy's Rural Health Certificate program, which partners with rural pharmacies and prepares students to serve the unique needs of rural areas. Notes the heightened importance of rural pharmacists, who may be more accessible than other health professionals in rural areas.
Source: The University of Tennessee Health Science Center
Apr 30, 2024 - Notice of final rule from the U.S. Department of Veterans Affairs (VA) amending its medical regulations regarding Civilian Health and Medical Program of the Department of Veterans Affairs (CHAMPVA) coverage. This rule removes the exclusion of audio-only telehealth visits. This rule also removes quantitative limitations on outpatient mental health visits and cost-sharing requirements for contraceptive services and contraceptive products approved, cleared, or granted by the U.S. Food and Drug Administration (FDA). This rule is effective May 30, 2024.
Source: Federal Register
Apr 23, 2024 - Notice of final rule from the Centers for Medicare & Medicaid Services (CMS) revising regulations for Medicare Advantage (Part C), Medicare Prescription Drug Benefit (Part D), Medicare cost plan, and Programs of All-Inclusive Care for the Elderly (PACE). Revisions include Star Ratings, marketing and communications, agent/broker compensation, health equity, dual-eligible special needs plans (D-SNPs), utilization management, network adequacy, and other programmatic areas. These regulations are effective June 3, 2024.
Source: Federal Register
Apr 23, 2024 - Notice from the Food and Drug Administration (FDA) seeking comments on a proposed generic information collection to support social and behavioral research used by FDA about drug products. Comments are due by June 24, 2024.
Source: Federal Register
Apr 19, 2024 - Notice of final rule from the Health Resources and Services Administration (HRSA) revising the 340B Administrative Dispute Resolution (ADR) process to address policy and operational challenges to the implementation of the December 14, 2020, final rule. Among other things, revisions intend to make 340B ADR process more accessible, administratively feasible, and timely, and require that the 340B ADR Panel members have specific knowledge of the authorizing statute and the operational processes of the 340B Program. This rule is effective June 18, 2024.
Source: Federal Register